These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 4049487)

  • 1. Exposure of newborn infants to plasticizers. Plasma levels of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate during exchange transfusion.
    Sjöberg PO; Bondesson UG; Sedin EG; Gustafsson JP
    Transfusion; 1985; 25(5):424-8. PubMed ID: 4049487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dispositions of di- and mono-(2-ethylhexyl) phthalate in newborn infants subjected to exchange transfusions.
    Sjöberg P; Bondesson U; Sedin G; Gustafsson J
    Eur J Clin Invest; 1985 Dec; 15(6):430-6. PubMed ID: 3938415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of phthalic acid, mono-(2-ethylhexyl) phthalate and di-(2-ethylhexyl) phthalate in human plasma and in blood products.
    Shintani H
    J Chromatogr; 1985 Feb; 337(2):279-90. PubMed ID: 3988859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to Di(2-ethylhexyl)phthalate in humans during pregnancy. A preliminary report.
    Latini G; De Felice C; Presta G; Del Vecchio A; Paris I; Ruggieri F; Mazzeo P
    Biol Neonate; 2003; 83(1):22-4. PubMed ID: 12566679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants.
    Green R; Hauser R; Calafat AM; Weuve J; Schettler T; Ringer S; Huttner K; Hu H
    Environ Health Perspect; 2005 Sep; 113(9):1222-5. PubMed ID: 16140631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of orally administered di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate in the rat.
    Teirlynck OA; Belpaire F
    Arch Toxicol; 1985 Sep; 57(4):226-30. PubMed ID: 4091646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-linearities in the pharmacokinetics of di-(2-ethylhexyl) phthalate and metabolites in male rats.
    Sjöberg P; Bondesson U; Hammarlund M
    Arch Toxicol; 1985 Dec; 58(2):72-7. PubMed ID: 4091659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP.
    Koch HM; Bolt HM; Angerer J
    Arch Toxicol; 2004 Mar; 78(3):123-30. PubMed ID: 14576974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate in blood and of DEHP metabolites in urine of male volunteers after single ingestion of ring-deuterated DEHP.
    Kessler W; Numtip W; Völkel W; Seckin E; Csanády GA; Pütz C; Klein D; Fromme H; Filser JG
    Toxicol Appl Pharmacol; 2012 Oct; 264(2):284-91. PubMed ID: 22963843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The accumulation of mono-2-ethylhexylphthalate (MEHP) during storage of whole blood and plasma.
    Rock G; Secours VE; Franklin CA; Chu I; Villeneuve DC
    Transfusion; 1978; 18(5):553-8. PubMed ID: 705860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets.
    Kessler W; Numtip W; Grote K; Csanády GA; Chahoud I; Filser JG
    Toxicol Appl Pharmacol; 2004 Mar; 195(2):142-53. PubMed ID: 14998681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit.
    Calafat AM; Needham LL; Silva MJ; Lambert G
    Pediatrics; 2004 May; 113(5):e429-34. PubMed ID: 15121985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Di-2-ethylhexyl phthalate (DEHP) and mono-2-ethylhexyl phthalate (MEHP) accumulation in whole blood and red cell concentrates.
    Peck CC; Odom DG; Friedman HI; Albro PW; Hass JR; Brady JT; Jess DA
    Transfusion; 1979; 19(2):137-46. PubMed ID: 432924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine disruption: In silico perspectives of interactions of di-(2-ethylhexyl)phthalate and its five major metabolites with progesterone receptor.
    Sheikh IA; Abu-Elmagd M; Turki RF; Damanhouri GA; Beg MA; Al-Qahtani M
    BMC Struct Biol; 2016 Sep; 16(Suppl 1):16. PubMed ID: 27719669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma phthalate levels in pubertal gynecomastia.
    Durmaz E; Ozmert EN; Erkekoglu P; Giray B; Derman O; Hincal F; Yurdakök K
    Pediatrics; 2010 Jan; 125(1):e122-9. PubMed ID: 20008419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis.
    Pollack GM; Buchanan JF; Slaughter RL; Kohli RK; Shen DD
    Toxicol Appl Pharmacol; 1985 Jun; 79(2):257-67. PubMed ID: 4002227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to phthalates in neonatal intensive care unit infants: urinary concentrations of monoesters and oxidative metabolites.
    Weuve J; Sánchez BN; Calafat AM; Schettler T; Green RA; Hu H; Hauser R
    Environ Health Perspect; 2006 Sep; 114(9):1424-31. PubMed ID: 16966100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of di(2-ethylhexyl) phthalate (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP) in rats: in vivo and in vitro dose and time dependency of metabolism.
    Lhuguenot JC; Mitchell AM; Milner G; Lock EA; Elcombe CR
    Toxicol Appl Pharmacol; 1985 Aug; 80(1):11-22. PubMed ID: 4024100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.
    Barr DB; Silva MJ; Kato K; Reidy JA; Malek NA; Hurtz D; Sadowski M; Needham LL; Calafat AM
    Environ Health Perspect; 2003 Jul; 111(9):1148-51. PubMed ID: 12842765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of di(2-ethylhexyl) phthalate and four of its metabolites in blood plasma by gas chromatography-mass spectrometry.
    Sjöberg P; Bondesson U
    J Chromatogr; 1985 Nov; 344():167-75. PubMed ID: 4086538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.